Background
==========

Domestic dogs and cats are very well known to develop chronic hepatic diseases. Hepatic lipidosis (HL) or fatty liver is an important liver disease in cats. It is characterized by excess fat accumulation in the liver and seems to have no age, breed, or gender predilection \[[@B1],[@B2]\]. HL is more common in obese or previously obese cats which have undergone brief periods of anorexia or food deprivation \[[@B3]\]. Obesity in cats has been described as the most prevalent nutritional disease of the domestic cat in the United States of America \[[@B4]\]. Cornelius and DeNovo \[[@B5]\] reported HL as the underlying disease process in 12.5% of 80 cats with icterus.

Chronic hepatitis is a well-recognized problem in canine practice and affects dogs of many breeds \[[@B6]\]. However, knowledge of its etiology in dogs remains limited \[[@B7]\]. If chronic hepatitis is not treated, it can lead to the development of liver cirrhosis, which is characterized by architectural distortion of lobules, bile duct hyperplasia, nodular regeneration and fibrosis \[[@B7]\].

Murine models of diffuse liver disease can be used as a base for pre-clinical studies \[[@B8]\]. Radiological methods such as ultrasound (US) brightness-mode (B-mode) imaging \[[@B1],[@B2],[@B9]-[@B11]\], duplex Doppler US \[[@B12]\], computed tomography perfusion \[[@B13]\] and magnetic resonance imaging (MRI) \[[@B14],[@B15]\] have been used to detect and to follow-up experimental diffuse liver disease models. Additionally, Quintanilha *et al*\[[@B16]\] utilized US B-mode imaging in a longitudinal study to follow-up the effects of bone marrow stem cell therapy in rats submitted to liver injury, while Ju *et al*\[[@B17]\] prospectively tracked stem cells labeled with super paramagnetic particles transplanted intrasplenically in cirrhotic rats by MRI.

US examination has been extensively used to detect fatty liver disease and cirrhosis \[[@B18]-[@B20]\]. In cats and dogs, fatty liver disease can be diagnosed by the observation of an increased hepatic echogenicity, characterized by hyperechoic liver parenchymal texture compared to the renal cortex, and decreased visualization of deeper structures, such as the diaphragm and small peripheral vessels \[[@B21],[@B22]\]. Cirrhosis, on the other hand, can be detected by a coarse and heterogeneous parenchymal echogenicity, irregular or nodular liver surface \[[@B21]-[@B23]\], focal regenerative nodules \[[@B21],[@B24]\], decreased right lobe to caudate lobe ratio, indicating volume redistribution \[[@B25]\], and by indirect evidence of portal hypertension, such as increased portal vein diameter (PVD), presence of collateral vessels, splenomegaly and ascites \[[@B21],[@B23],[@B26]\].

Even though there are a number of studies that use US B-mode to evaluate liver diseases in rodents \[[@B9],[@B27],[@B28]\], few of these studies have statistically correlated US findings to the histological alterations present in liver parenchyma \[[@B29]-[@B31]\]. Lee *et al*\[[@B29]\] compared histopathological findings to the US B-mode quantitative parameter Mean Grey Level in CCl~4~-induced liver cirrhosis, while Matsuhashi *et al*\[[@B30]\] and Layer *et al*\[[@B31]\] correlated histology to Hepatic Ultrasound Speed and Texture Analysis respectively.

However, regardless of the fact that there is a correlation between quantitative B-mode methods and the histological features of cirrhosis, qualitative ultrasonography, which is the most common evaluation method of liver diseases in clinical practice both in animals and in humans, remains to be validated as a technique for the non-invasive diagnosis of such diseases in rodents. The purpose of our study was to determine the reliability of US qualitative findings in the assessment of fatty liver disease and cirrhosis in Wistar rats in comparison to histological results by following up a murine model of hepatic disease induced by dual exposure to CCl~4~and ethanol.

Methods
=======

Animals
-------

This investigation was performed in agreement with the Guide for Care and Use of Laboratory Animals \[DHHS Publication No. (NIH) 85-23, revised 1996, Office of Science and Health Reports, Bethesda, MD 20892\] and the authors have received approval from the Institutional Animal Care and Use Committee (protocol \#021).

Female Wistar rats with 6 - 12 months of age, weighing between 160 - 180 g were housed at controlled temperature (23°C) with daily exposure to a 12:12 light-dark cycle.

Model of Experimental Cirrhosis
-------------------------------

Animals (n = 40) were randomly divided into two groups: the Control group (n = 10) was fed with standard rat chow and water, and the Experimental group (n = 30) had chronic liver damage induced according to the protocol previously described by Dias et al \[[@B10]\], Quintanilha et al \[[@B16]\] and Carvalho et al \[[@B32]\]. Briefly, liver damage was induced with injections of a 20% solution of carbon tetrachloride (CCl~4~) (1:5 in olive oil, dose of 0.05 mL/kg) intraperitoneally three times a week on alternate days combined with an alcoholic liquid diet in accordance with the AIN-93 guidelines \[[@B33]\] over 15 weeks.

Ultrasound Analysis
-------------------

The Control and the Experimental groups were examined at the beginning of the experiment and after 4, 8 and 15 weeks of liver injury induction. Animals were anesthetized using ketamine (0.5 mL/kg) and xilazin (1 mL/kg) and had the abdomen shaved to reduce imaging artifacts in the ultrasonographic examination. A sound-conducting gel (Carbogel^®^, Brazil) was applied and an US examination was performed by two blinded expertise authors by consensus (reader 1, A.S.L., with 7 years experience, reader 10, C.M.C.R., with 26 years experience) by using a multifrequency linear transducer (7.5 to 10 MHz) and a Caris Plus^®^ultrasound equipment (Esaote, Italy). All imaging was performed in fundamental brightness mode (B-mode). Two-dimensional B-mode image plans were acquired with optimization of the gain and the time gain compensation settings, which were kept constant throughout the experiment. The acoustic focus was placed in the center of the target organ (liver) and in the largest transverse cross section of the spleen. The animals were examined in supine position to assess the liver and the portal vein, and in the right posterior oblique position to assess the spleen. These organs were evaluated by multiple transversal and longitudinal scans.

Ultrasonographic findings were analyzed based on our previous observations and on criteria for US diagnosis in humans according to the following classification:

A. Changes in the liver echogenicity, classified into four patterns: (1) homogeneous liver parenchyma with medium level echogenicity and a regular hepatic surface; (2) diffusely increased parenchymal echogenicity, reduced visualization of the diaphragm and small peripheral vessels in the liver with no change on liver surface; (3) discrete coarse and heterogeneous parenchymal echogenicity, dotted or slightly irregular liver surface; (4) extensive coarse and heterogeneous parenchymal echogenicity, irregular or nodular hepatic surface reflecting the presence of underlying regenerative nodules;

B. Inversion of the echographic relationship between the liver and the renal cortex. This finding was considered to be positive if the echogenicity of the liver parenchyma was greater or equal to that of the right renal cortex;

C. Increased PVD. It was measured in the mid-point of the main portal vein by using calipers of the scanner. PVD was considered to be abnormal if equal or greater than 2.1 mm;

D. Presence of ascites;

E. Spleen area. It was directly calculated by the US software after organ surface was delineated by the examiner.

Histological analysis
---------------------

Rats from the Experimental and Control Groups were sacrificed on the 4^th^(n = 6), 8^th^(n = 7) and 15^th^(n = 17) week of the cirrhosis induction protocol. The liver was removed from the abdominal cavity for macroscopic post mortem analysis. For microscopic examination, liver tissue was fixed for 5 h in Gendre\'s solution followed by overnight incubation in 10% buffered formalin solution (pH 7.2) and embedded in paraffin. Liver samples were sectioned (5 μm) and stained with hematoxilin and eosin (H&E) \[[@B34]\] or Sirius Red \[[@B35]\] according to standard protocols.

The histological diagnosis of fatty liver disease and cirrhosis was defined by a single blinded experienced pathologist based on the hepatic steatosis grading established by Ishak *et al*\[[@B36]\] and on the scoring system for hepatic fibrosis described by Plummer *et al*\[[@B37]\], respectively. Histology was used as the gold standard for both the diagnosis of fatty liver disease and cirrhosis and for the comparison with US results.

Statistical Analysis
--------------------

The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the US findings for the detection of fatty liver disease and cirrhosis were calculated in comparison to the histological diagnosis \[[@B38]\]. PVD values were analyzed using analysis of variance (ANOVA) with Tukey\'s post-test for multiple comparisons. The value of *p*\< 0.01 was considered statistically significant. Data are presented as mean ± SD. We also performed a Receiver Operating Characteristic (ROC) analysis of these data.

Results
=======

Ultrasound Imaging
------------------

All animals were examined by US imaging in the beginning of experiment and after 4, 8 and 15 weeks of liver injury induction and the alterations found in the Experimental group were homogeneous in each examination time point. These alterations were represented by changes in liver echogenicity, in the relationship between liver parenchyma and renal cortex echogenicity, increased values of PVD and higher incidence of ascites when compared to the Control group (Table [1](#T1){ref-type="table"}). A subset of animals in the Experimental group was sacrificed after 4 (n = 6) and 8 (n = 7) weeks of liver injury induction for histological studies, while the remaining animals (n = 17) were sacrificed after 15 weeks.

###### 

Ultrasound findings over the time of experiment observed in Experimental group compared to Control group

  US findings/Time of experiment                                          Control Group at any time (n = 10)   Experimental Group                          
  ----------------------------------------------------------------------- ------------------------------------ --------------------- --------------------- -----------------------
                                                                                                               **4 weeks (n = 6)**   **8 weeks (n = 7)**   **15 weeks (n = 17)**
                                                                                                                                                           
  Homogeneous liver parenchyma of medium level echogenicity (pattern 1)   10                                   3                     0                     0
                                                                                                                                                           
  Diffusely increased parenchymal echogenicity (pattern 2)                0                                    3                     3                     0
                                                                                                                                                           
  Discrete coarsened and heterogeneous parenchyma (pattern 3)             0                                    0                     4                     5
                                                                                                                                                           
  Extensive coarsened and heterogeneous parenchyma (pattern 4)            0                                    0                     0                     12
                                                                                                                                                           
  L-Echo\<R-Echo                                                          10                                   3                     0                     0
                                                                                                                                                           
  L-Echo=R-Echo                                                           0                                    2                     4                     8
                                                                                                                                                           
  L-Echo\>R-Echo                                                          0                                    1                     3                     9
                                                                                                                                                           
  Liver isoechoic nodule                                                  0                                    0                     0                     2
                                                                                                                                                           
  Liver hypoechoic nodule                                                 0                                    0                     0                     1
                                                                                                                                                           
  PVD\< 2.1 mm                                                            10                                   6                     6                     0
                                                                                                                                                           
  PVD ≥ 2.1 mm                                                            0                                    0                     1                     17
                                                                                                                                                           
  Mild or transient ascites                                               0                                    0                     0                     2
                                                                                                                                                           
  Moderate or marked ascites                                              0                                    0                     0                     3

PVD: Portal Vein Diameter; L-Echo: Liver echogenicity; R-Echo: Renal cortex echogenicity.

Histological Analysis
---------------------

Control group showed a normal architecture with hepatocytes radially arranged in plates aligned to sinusoids converging to centrolobular veins and without evidence of fibrosis (Figure [1a](#F1){ref-type="fig"}). On the other hand, the Experimental group showed liver parenchymal alterations that correlated to the time of injury induction. After 4 weeks (n = 6), half of the animals presented with mild steatosis without fibrous septa and the other half showed mild to moderate steatosis with minimal focal pericellular and perivenular fibrosis (Figure [1b](#F1){ref-type="fig"}). After 8 weeks (n = 7), all the animals showed moderate to marked steatosis with some fibrous septa linking centrolobular veins to portal tracts, although liver parenchymal architecture was preserved (Figure [1c](#F1){ref-type="fig"}). After 15 weeks of induction (n = 17), all rats had macronodular cirrhosis, characterized by global architectural distortion and formation of regenerative nodules surrounded by collagen septa and containing some inflammatory infiltrate (Figure [1d](#F1){ref-type="fig"}). Mild to moderate steatosis was also present.

![**Histological findings observed over the experiment**. (a) Microscopy of Control group (normal liver): Hematoxilin/Eosin (H&E) section (magnification 100×) shows hepatocytes radially arranged in plates aligned to sinusoids (arrowheads). Sirius red (magnification 100×) staining shows only vessels stained in red (portal triad - PT), which is a normal place of collagen deposit. (b) After 4 weeks of experiment: H&E section (magnification 100×) shows moderate steatosis (arrows). Sirius red (magnification 100×) staining shows focal perivenular and pericellular fibrosis (arrowheads). (c) After 8 weeks of experiment H&E section (magnification 100×) shows moderate steatosis (arrows) with some fibrosis (arrowheads) but preserved liver parenchymal architecture. Sirius red (magnification 100×) staining some fibrous septa linking centrolobular veins with portal tracts (arrowheads). (d) After 15 weeks of protocol: H&E section (magnification 100×) shows macronodular cirrhosis, characterized by thick collagen septa, forming regenerative nodules, global architectural distortion, some inflammatory infiltrate (arrow) and steatosis. Sirius red (magnification 100×) staining shows thick collagen septa (arrowheads) linking portal tracts, centrolobular veins, and portal tracts to centrolobular veins, forming regenerative nodules (RN).](1746-6148-6-6-1){#F1}

The prevalence of fatty liver disease among the 30 rats in the Experimental group was 100%, while the prevalence of cirrhosis was 56.7% (17 out of 30) when considering all the time points examined together. The lower prevalence of cirrhosis is expected since animals take longer periods of time to fully develop the histological alterations found in this disease. Accordingly, if we consider only the subset of animals that were injured for 15 weeks, the prevalence of cirrhosis was also 100%. No animals in the Control group presented with fatty liver disease or cirrhosis.

Correlation between Ultrasound Findings and Histological Diagnosis
------------------------------------------------------------------

Ultrasound and histological findings among the experimental groups were compared in the different time points (Table [2](#T2){ref-type="table"}, Figure [2](#F2){ref-type="fig"}). Samples of acquired US data used to perform correlation analysis can be seen in additional files (additional file [1](#S1){ref-type="supplementary-material"}, [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"}, [4](#S4){ref-type="supplementary-material"} and [5](#S5){ref-type="supplementary-material"})

![**Correlation between ultrasound and histological findings**. (a) Sonograms and macroscopy of Control group (normal liver): Transversal sonogram demonstrates homogeneous liver parenchyma, with medium level echogenicity and a regular hepatic surface (arrowheads). Parasagittal sonogram presents right renal cortex more echogenic than liver. Macroscopy shows smooth surface, brownish-red color and friable consistency. (b) Sonograms and macroscopy of fatty liver: Transversal sonogram presents diffusely increased parenchymal echogenicity. Parasagittal sonogram demonstrates hepatic echogenicity greater than that of right renal cortex. Macroscopy exhibits wrinkled surface, yellowish color and friable consistency. (c) Sonograms and macroscopy of liver carrying steatosis and fibrosis: Transversal sonogram shows discrete coarse and heterogeneous parenchymal echogenicity and the liver surface as a dotted or slightly irregular line (arrowheads). Parasagittal sonogram presents hepatic echogenicity equal to the right renal cortex echogenicity and a slightly irregular liver surface (arrowhead). Macroscopy shows a slightly irregular surface, pale red color and more rigid consistency. (d) Sonograms and macroscopy of cirrhotic liver: Transversal sonogram presents extensive coarse and heterogeneous parenchymal echogenicity, extremely irregular hepatic surface (arrowheads), a hypoechoic regenerative nodule (arrow) and mild ascites (\*). Parasagittal sonogram shows hepatic echogenicity slightly greater than that of the right renal cortex, extremely irregular liver surface (arrowhead) and mild ascites (\*). Macroscopy reveals extremely irregular surface, reflecting the presence of underling regenerative nodules, reddish color and rigid consistency.](1746-6148-6-6-2){#F2}

###### 

Ultrasound findings compared to histological diagnosis

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Histologic Diagnosis                                                                                                                                                                                                            
  --------------------------- --------------------- -------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
  **US findings**             **Normal (n = 10)**   **Mild steatosis without fibrous septa (n = 3)**   **Mild to marked hepatic steatosis with various degrees of fibrosis but intact liver parenchymal architecture (n = 10)**   **Macronodular cirrhosis with hepatic steatosis(n = 17)**

                                                                                                                                                                                                                                  

  Pattern 1 L-Echo\           10                    3                                                  0                                                                                                                          0
  L-Echo \< R-Echo                                                                                                                                                                                                                

                                                                                                                                                                                                                                  

  Pattern 1 L-Echo\           0                     0                                                  0                                                                                                                          0
  L-Echo ≥ R-Echo                                                                                                                                                                                                                 

                                                                                                                                                                                                                                  

  Pattern 2, 3 or 4 L-Echo\   0                     0                                                  0                                                                                                                          0
  L-Echo \< R-Echo                                                                                                                                                                                                                

                                                                                                                                                                                                                                  

  Pattern 2 L-Echo\           0                     0                                                  6                                                                                                                          0
  L-Echo ≥ R-Echo                                                                                                                                                                                                                 

                                                                                                                                                                                                                                  

  Pattern 3 L-Echo\           0                     0                                                  4                                                                                                                          5
  L-Echo ≥ R-Echo                                                                                                                                                                                                                 

                                                                                                                                                                                                                                  

  Pattern 4 L-Echo\           0                     0                                                  0                                                                                                                          12
  L-Echo ≥ R-Echo                                                                                                                                                                                                                 

                                                                                                                                                                                                                                  

  Liver nodules               0                     0                                                  0                                                                                                                          3 (regenerative nodules)

                                                                                                                                                                                                                                  

  PVD \< 2.1 mm               10                    3                                                  9                                                                                                                          0

                                                                                                                                                                                                                                  

  PVD ≥ 2.1 mm                0                     0                                                  1                                                                                                                          17

                                                                                                                                                                                                                                  

  Presence of ascites         0                     0                                                  0                                                                                                                          5
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

L-Echo: Liver echogenicity; Pattern 1: normal echogenicity, pattern 2: diffusely increased echogenicity, pattern 3: slightly coarse echogenicity, and pattern 4: coarse and heterogeneous echogenicity; R-Echo: Renal cortex echogenicity; PVD: Portal Vein Diameter.

### Liver echogenicity

The increase in liver echogenicity compared to right renal cortex echogenicity (L-Echo ≥ R-Echo) had a sensitivity of 90% (27 out of 30), specificity of 100% (10 out of 10), positive predictive value of 100% (27 out of 27), negative predictive value of 76.9% (10 out of 13) and accuracy of 92.5% (37 out of 40) for the detection of fatty liver disease and were well correlated with patterns 2 and 3 of liver echogenicity. The 3 rats which appeared to be normal in ultrasound imaging showed mild steatosis in microscopy. Control animals were all classified as pattern 1 and presented with normal liver parenchyma.

Moreover, pattern 4, characterized by extensive coarse and heterogeneous parenchymal echogenicity and irregular or nodular hepatic surface, was always associated with alteration of the echographic relationship between the liver and the right renal cortex. It had a sensitivity of 70.6% (12 out of 17), specificity of 100% (23 out of 23), positive predictive value of 100% (12 out of 12), negative predictive value of 82.1% (23 out of 28) and accuracy of 87.5% (35 out of 40) for the detection of liver cirrhosis.

### Portal Vein Diameter (PVD)

In the Experimental group, portal vein became wider and tortuous during hepatic disease development when compared to Control group (Figure [3](#F3){ref-type="fig"}). We analyzed PVD values among rats with cirrhosis, rats with steatosis and fibrosis and rats from the Control group. The results found were 2.2 ± 0.2 mm, 1.8 ± 0.2 mm and 1.5 ± 0.2 mm, respectively. PVD was significantly higher in cirrhotic rats and in rats with steatosis and fibrosis in comparison to the Control group (Figure [4](#F4){ref-type="fig"}), suggesting the presence of portal hypertension.

![**Portal vein widening over the experiment**. (a) Parasagittal sonogram shows a straight and thin portal vein (diameter = 1.5 mm) in a Control group rat (arrowheads). (b) Parasagittal sonogram demonstrates a slightly tortuous and thin portal vein (diameter = 2.0 mm) in a rat with hepatic steatosis and fibrosis (arrowheads). (c) Parasagittal sonogram presents a tortuous and wide portal vein (diameter = 2.4 mm) in a cirrhotic rat (arrowheads).](1746-6148-6-6-3){#F3}

![**Comparison between portal vein diameter and histological findings**. Quantification of portal vein diameter shows increase in this value in the group of cirrhotic rats (mean = 2.2 mm) and in the group of rodents with steatosis and fibrosis (mean = 1.8 mm) compared to the Control group (mean = 1.5 mm). Data are shown as mean ± SD and the test utilized was ANOVA with the Tukey\'s post-test for multiple comparisons.](1746-6148-6-6-4){#F4}

After Receiver Operating Characteristic (ROC) analysis of these data (Figure [5](#F5){ref-type="fig"}), we found that PVD values equal or greater than 2.1 mm had sensitivity of 100%, specificity of 90.5%, positive predictive value of 89.5% and negative predictive value of 100% for the detection of cirrhosis. Thus, this value can be considered a cut-off point for the diagnosis of cirrhosis in rats.

![**ROC (Receiver Operating Characteristic) analysis of Portal Vein Diameter (PVD) values**.](1746-6148-6-6-5){#F5}

### Presence of ascites and spleen measurements

Furthermore, the occurrence of ascites could be easily identified, even when small quantities of fluid were present in the abdominal cavity. This alteration was observed in 5 out of 17 cirrhotic rats (34%).

We also compared the spleen area among rats with cirrhosis, rats with steatosis and fibrosis and rats from the Control group. The results found were 1.19 ± 0.16 cm^2^, 1.16 ± 0.14 cm^2^and 1.18 ± 0.16 cm^2^, respectively. There were no statistical differences among the three groups analyzed, indicating that splenomegaly was not a prominent feature in cirrhotic rats.

Discussion
==========

In this work we demonstrated that qualitative ultrasound analysis is sensitive and specific enough to diagnose fatty liver disease and cirrhosis in rats and, therefore, can reliably substitute histological diagnosis in experimental liver disease models. Ultrasound imaging has many advantages, namely its low cost, extensive availability and the fact that it can be easily done in murine models. Only slight sedation and abdominal shaving are required, not demanding total immobility or apnea while obtaining the images \[[@B39]\], therefore, consisting in a low risk procedure. Moreover, it is an accurate, innocuous and non-invasive technique and it is the most commonly used method for the investigation of liver diseases in humans and small animals \[[@B1],[@B18]-[@B21],[@B40],[@B41]\].

Although ultrasound is an essentially subjective diagnostic method, its validity as an imaging technique for liver evaluation has been extensively described in the literature for humans \[[@B40],[@B42]\], dogs \[[@B21]-[@B23]\] and cats \[[@B1],[@B21]\]. In our study, we focused our attention in a rodent model of liver disease, since these are the most commonly used models in pre-clinical studies \[[@B37],[@B43]-[@B46]\]. The rat model was chosen because they are larger than mice, facilitating US imaging procedure.

Healthy rats showed homogeneous liver parenchyma, with medium level echogenicity and regular liver surface, as previously described in humans \[[@B47]\], dogs \[[@B21],[@B23],[@B48]\] and cats \[[@B2],[@B21]\]. Liver echogenicity was lower in comparison to the right renal cortex, a finding that contrasts with humans \[[@B47]\], but is in accordance to what has been described in dogs \[[@B49]\]. In cats, renal cortical echogenicity varies in normal animals \[[@B50]\]. Fatty liver disease in rats was characterized by homogeneous and diffusely increased echogenicity (\"bright liver\"), equal or greater to the right renal cortex, reduced visualization of the diaphragm and of small peripheral vessels, and by no changes in liver surface, as described in humans \[[@B51]\], dogs \[[@B21],[@B23]\], and cats \[[@B1],[@B21]\].

Liver echogenicity increases due to the presence of fatty infiltration and/or fibrosis \[[@B21],[@B23]\], changing the relation between liver and right renal cortex echogenicity \[[@B21],[@B22]\]. This finding had high sensitivity (90%), specificity (100%), positive and negative predictive values (100% and 76.9%), and accuracy (92.5%) for the detection of fatty liver disease, values that were compatible with the ones previously described in the literature. The increased liver echogenicity has been reported to have sensitivity of 60 to 82% \[[@B1],[@B23],[@B52]\], specificity of 97 to 100% \[[@B1],[@B52]\] and positive predictive value of 96 to 100% \[[@B1],[@B52]\] for detection of fatty liver disease. However, it is important to exclude kidney diseases when utilizing this approach \[[@B23]\].

Three rats with mild hepatic steatosis appeared to be normal in US examination, which is also comparable to previous reports in the literature \[[@B23],[@B52]\]. US has been reported to have sensitivity of 90 - 91% for the detection of moderate to marked steatosis, but its sensitivity decreases to 30 - 64% when steatosis is mild \[[@B23],[@B52]\].

The finding of an extensive coarse and heterogeneous parenchyma associated to irregular or nodular hepatic surface proved to be relevant in the detection of cirrhosis with sensitivity of 70.6%, specificity of 100%, positive predictive value of 100%, negative predictive value of 82.1% and accuracy of 87.5%, as seen in humans \[[@B40],[@B53]\] and in dogs \[[@B23]\]. Its presence implied a definitive diagnosis of cirrhosis since there were no false negative results. Therefore, US imaging can consistently substitute histology to diagnose cirrhosis in rats, constituting a useful method to avoid unnecessary animal sacrifice or repeated liver biopsies when following long experimental protocols.

The evaluation of portal hypertension is also important to assess the severity of liver diseases \[[@B20],[@B21],[@B40]\] and one of its most important signs is the widening of the portal vein \[[@B20],[@B21],[@B47]\]. PVD was statistically different when comparing cirrhotic to non-cirrhotic rats (p \< 0.001). An increase in its caliber when equal or superior to 2.1 mm can be considered a relevant ultrasound finding with sensitivity of 100%, specificity of 90.5%, positive predictive value of 89.5% and negative predictive value of 100% for the detection of cirrhosis. There was one false positive, a rat bearing liver steatosis with fibrosis. There were no false negatives since none of the rats with PVD lower than 2.1 mm were cirrhotic. Additionally, PVD measurements were unable to distinguish normal from steatotic livers because of the considerable overlap between PVD values encountered in normal rats compared to rats carrying steatosis and fibrosis. This fact is, nonetheless, expected since fatty liver disease does not lead to portal hypertension and, consequently, to the widening of the portal vein. Doppler evaluation of the portal vein was also tried, yet it was not possible due to technical difficulties. The caliper could not be stably positioned inside such a small vessel, we could not induce apnea and whirl flow was found even in normal rats, causing an oscillation between hepatopetal and hepatofugal flow.

The presence of ascites, which is also an important indicator of the severity of liver disease, could be detected even when the amount of fluid present in the peritoneal cavity was small, as previously reported by Vörös et al \[[@B54]\]. Among the imaging diagnostic methods, ultrasound is considered ideal for the study of ascites \[[@B6],[@B21],[@B23]\]. In our study, its presence invariably corresponded to cirrhosis in histology, although only 5 animals presented with ascites out of 17 cirrhotic rats. This was, however, expected since ascites is only observed when cirrhosis is decompensated. In addition, although splenomegaly should be expected in severe cirrhosis with portal hypertension, there were no statistical differences in splenic area among the three groups analyzed, indicating that splenomegaly was not a prominent feature in our study of cirrhotic rats.

Conclusion
==========

The use of ultrasound imaging in the diagnosis of murine liver disease models is feasible and efficient, especially when different parameters (liver echogenicity and its correlation to that of the right renal cortex, PVD and the presence of ascites) are used in combination. The implication of this study is to certify that fatty liver disease and cirrhosis can be reliably diagnosed by a non-invasive method that allows adequate long-term follow-up, which is usually needed in pre-clinical drug or cell-based therapy studies.
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###### Additional file 1

**Ultrasound imaging of Control group (transversal and parasagittal views)**. The exam begins making transversal scanning, which shows homogeneous liver parenchyma, with medium level echogenicity and a regular hepatic surface. In the sequence, the parasagittal scanning shows right renal cortex more echogenic than liver. Author: Lessa AS. Length: 31 seconds. Size: 2.65 MB.

###### 

Click here for file

###### Additional file 2

**Ultrasound imaging of steatotic liver (transversal view)**. Transversal scanning shows diffusely increased parenchymal echogenicity. Author: Lessa AS. Length: 35 seconds. Size: 3.02 MB.
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###### Additional file 3

**Ultrasound imaging of steatotic liver (parasagittal view)**. Parasagittal sacanning shows hepatic echogenicity slightly greater than that of right renal cortex. Author: Lessa AS. Length: 10 seconds. Size: 0.39 MB.
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###### Additional file 4

**Ultrasound imaging of cirrhotic liver (transversal view)**. Transversal scanning shows marked ascites, extensive coarse and heterogeneous parenchymal echogenicity and extremely irregular hepatic surface. Author: Resende CMC. Length: 35 seconds. Size: 3.06 MB.
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###### Additional file 5

**Ultrasound imaging of cirrhotic liver (parasagittal view)**. Parasagittal scanning shows hepatic echogenicity equal to that of the right renal cortex, extremely irregular liver surface, tortuous and wide portal vein and marked ascites. Author: Resende CMC. Length: 70 seconds. Size: 6.06 MB.
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